Phylogenetic and molecular analysis of food-borne shiga toxin-producing escherichia coli

Applied and Environmental Microbiology

Volumn 79, Issue 8, 2013, Pages 2731-2740

  Hauser, Elisabeth ^a   Mellmann, Alexander ^b   Semmler, Torsten ^c   Stoeber, Helen ^a   Wieler, Lothar H ^c   Karch, Helge ^b   Kuebler, Nikole ^a   Fruth, Angelika ^d   Harmsen, Dag ^e   Weniger, Thomas ^e   Tietze, Erhard ^d   Schmidt, Herbert ^a  

^a UNIVERSITY OF HOHENHEIM   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

^d ROBERT KOCH INSTITUTE   (Germany)

^e UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; CHROMOSOMAL INTEGRATION; HUMAN INFECTION; MOLECULAR ANALYSIS; MULTILOCUS SEQUENCE TYPING; PATHOGENIC POTENTIAL; SHIGA TOXIN-PRODUCING ESCHERICHIA COLI; VIRULENCE GENE;

CHROMOSOMES;

ESCHERICHIA COLI;

ANTIINFECTIVE AGENT; BACTERIAL DNA; ESCHERICHIA COLI PROTEIN; SHIGA TOXIN;

ANTIBIOTIC RESISTANCE; CHROMOSOME; DISEASE PREVALENCE; FOOD; INFECTIOUS DISEASE; MICROBIAL COMMUNITY; MOLECULAR ANALYSIS; PATHOGENICITY; PHYLOGENETICS;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIOPHAGE; BIOSYNTHESIS; CLASSIFICATION; DNA SEQUENCE; ESCHERICHIA COLI INFECTION; FOOD CONTROL; GENETICS; GENOMIC ISLAND; HEMOLYTIC UREMIC SYNDROME; HUMAN; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTILOCUS SEQUENCE TYPING; NUCLEIC ACID AMPLIFICATION; NUCLEOTIDE SEQUENCE; PATHOGENICITY; PHYLOGENY; SHIGA TOXIN PRODUCING ESCHERICHIA COLI;

ANTI-BACTERIAL AGENTS; BACTERIOPHAGES; BASE SEQUENCE; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FOOD MICROBIOLOGY; GENOMIC ISLANDS; HEMOLYTIC-UREMIC SYNDROME; HUMANS; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PHYLOGENY; SEQUENCE ANALYSIS, DNA; SHIGA TOXIN; SHIGA-TOXIGENIC ESCHERICHIA COLI;

ESCHERICHIA COLI;

EID: 84876171524     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.03552-12     Document Type: Article

References (69)

1. Karmali MA. 1989. Infection by verocytotoxin-producing Escherichia coli. Clin. Microbiol. Rev. 2:15-38.
2. Griffin PM, Tauxe RV. 1991. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol. Rev. 13:60-98.
3. Nataro JP, Kaper JB. 1998. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11:142-201.
4. Melton-Celsa A, Mohawk K, Teel L, O'Brien A. 2012. Pathogenesis of Shiga-toxin producing Escherichia coli. Curr. Top. Microbiol. Immunol. 357:67-103.
5. Jarvis KG, Kaper JB. 1996. Secretion of extracellular proteins by enterohemorrhagic Escherichia coli via a putative type III secretion system. Infect. Immun. 64:4826-4829.
6. Schmidt H, Beutin L, Karch H. 1995. Molecular analysis of the plasmidencoded hemolysin of Escherichia coli O157:H7 strain EDL 933. Infect. Immun. 63:1055-1061.
7. Newton HJ, Sloan J, Bulach DM, Seemann T, Allison CC, Tauschek M, Robins-Browne RM, Paton JC, Whittam TS, Paton AW, Hartland EL. 2009. Shiga toxin-producing Escherichia coli strains negative for locus of enterocyte effacement. Emerg. Infect. Dis. 15:372-380.
8. Paton AW, Woodrow MC, Doyle RM, Lanser JA, Paton JC. 1999. Molecular characterization of a Shiga toxigenic Escherichia coli O113:H21 strain lacking eae responsible for a cluster of cases of hemolytic-uremic syndrome. J. Clin. Microbiol. 37:3357-3361.
9. Bonnet R, Souweine B, Gauthier G, Rich C, Livrelli V, Sirot J, Joly B, Forestier C. 1998. Non-O157:H7 Stx2-producing Escherichia coli strains associated with sporadic cases of hemolytic-uremic syndrome in adults. J. Clin. Microbiol. 36:1777-1780.
10. Beutin L, Martin A. 2012. Outbreak of Shiga toxin-producing Escherichia coli (STEC) O104:H4 infection in Germany causes a paradigm shift with regard to human pathogenicity of STEC strains. J. Food Prot. 75:408-418.
11. Mellmann A, Bielaszewska M, Köck R, Friedrich AW, Fruth A, Middendorf B, Harmsen D, Schmidt MA, Karch H. 2008. Analysis of collection of hemolytic uremic syndrome-associated enterohemorrhagic Escherichia coli. Emerg. Infect. Dis. 14:1287-1290.
12. Gyles CL. 2007. Shiga toxin-producing Escherichia coli: an overview. J. Anim. Sci. 85:E45-E62.
13. Martin A, Beutin L. 2011. Characteristics of Shiga toxin-producing Escherichia coli from meat and milk products of different origins and association with food producing animals as main contamination sources. Int. J. Food Microbiol. 146:99-104.
14. Bielaszewska M, Mellmann A, Zhang W, Köck R, Fruth A, Bauwens A, Peters G, Karch H. 2011. Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study. Lancet Infect. Dis. 11:671-676.
15. Robert Koch-Institut. 2011. Robert Koch-Institut Abschließende Darstellung und Bewertung der epidemiologischen Erkenntnisse im EHEC O104:H4 Ausbruch Deutschland 2011. Robert Koch-Institut, Berlin, Germany.
16. Frank C, Werber D, Cramer JP, Askar M, Faber M, an der Heiden M, Bernard H, Fruth A, Prager R, Spode A, Wadl M, Zoufaly A, Jordan S, Kemper MJ, Follin P, Muller L, King LA, Rosner B, Buchholz U, Stark K, Krause G, HUS Investigation Team. 2011. Epidemic profile of Shigatoxin-producing Escherichia coli O104:H4 outbreak in Germany. N. Engl. J. Med. 365:1771-1780.
17. Buchholz U, Bernard H, Werber D, Bohmer MM, Remschmidt C, Wilking H, Delere Y, an der Heiden M, Adlhoch C, Dreesman J, Ehlers J, Ethelberg S, Faber M, Frank C, Fricke G, Greiner M, Hohle M, Ivarsson S, Jark U, Kirchner M, Koch J, Krause G, Luber P, Rosner B, Stark K, Kuhne M. 2011. German outbreak of Escherichia coli O104:H4 associated with sprouts. N. Engl. J. Med. 365:1763-1770.
18. Karch H, Denamur E, Dobrindt U, Finlay BB, Hengge R, Johannes L, Ron EZ, Tonjum T, Sansonetti PJ, Vicente M. 2012. The enemy within us: lessons from the 2011 European Escherichia coli O104:H4 outbreak. EMBO Mol. Med. 4:841-848.
19. Werber D, Beutin L, Pichner R, Stark K, Fruth A. 2008. Shiga toxinproducing Escherichia coli serogroups in food and patients, Germany. Emerg. Infect. Dis. 14:1803-1806.
20. Wirth T, Falush D, Lan R, Colles F, Mensa P, Wieler LH, Karch H, Reeves PR, Maiden MC, Ochman H, Achtman M. 2006. Sex and virulence in Escherichia coli: an evolutionary perspective. Mol. Microbiol. 60: 1136-1151.
21. Bielaszewska M, Dobrindt U, Gartner J, Gallitz I, Hacker J, Karch H, Müller D, Schubert S, Alexander SM, Sorsa LJ, Zdziarski J. 2007. Aspects of genome plasticity in pathogenic Escherichia coli. Int. J. Med. Microbiol. 297:625-639.
22. Ogura Y, Ooka T, Iguchi A, Toh H, Asadulghani M, Oshima K, Kodama T, Abe H, Nakayama K, Kurokawa K, Tobe T, Hattori M, Hayashi T. 2009. Comparative genomics reveal the mechanism of the parallel evolution of O157 and non-O157 enterohemorrhagic Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 106:17939-17944.
23. Dobrindt U, Hentschel U, Kaper JB, Hacker J. 2002. Genome plasticity in pathogenic and nonpathogenic enterobacteria. Curr. Top. Microbiol. Immunol. 264:157-175.
24. Beutin L, Krüger U, Krause G, Miko A, Martin A, Strauch E. 2008. Evaluation of major types of Shiga toxin 2E-producing Escherichia coli bacteria present in food, pigs, and the environment as potential pathogens for humans. Appl. Environ. Microbiol. 74:4806-4816.
25. Bielaszewska M, Friedrich AW, Aldick T, Schurk-Bulgrin R, Karch H. 2006. Shiga toxin activatable by intestinal mucus in Escherichia coli isolated from humans: predictor for a severe clinical outcome. Clin. Infect. Dis. 43:1160-1167.
26. Slanec T, Fruth A, Creuzburg K, Schmidt H. 2009. Molecular analysis of virulence profiles and Shiga toxin genes in food-borne Shiga toxinproducing Escherichia coli. Appl. Environ. Microbiol. 75:6187-6197.
27. Mellmann A, Harmsen D, Cummings CA, Zentz EB, Leopold SR, Rico A, Prior K, Szczepanowski R, Ji Y, Zhang W, McLaughlin SF, Henkhaus JK, Leopold B, Bielaszewska M, Prager R, Brzoska PM, Moore RL, Guenther S, Rothberg JM, Karch H. 2011. Prospective genomic characterization of the German enterohemorrhagic Escherichia coli O104:H4 outbreak by rapid next generation sequencing technology. PLoS One 6:e22751. doi:10.1371/journal.pone.0022751.
28. Brzuszkiewicz E, Thurmer A, Schuldes J, Leimbach A, Liesegang H, Meyer FD, Boelter J, Petersen H, Gottschalk G, Daniel R. 2011. Genome sequence analyses of two isolates from the recent Escherichia coli outbreak in Germany reveal the emergence of a new pathotype: entero-aggregativehaemorrhagic Escherichia coli (EAHEC). Arch. Microbiol. 193:883-891.
29. Perna NT, Plunkett G, III, Burland V, Mau B, Glasner JD, Rose DJ, Mayhew GF, Evans PS, Gregor J, Kirkpatrick HA, Posfai G, Hackett J, Klink S, Boutin A, Shao Y, Miller L, Grotbeck EJ, Davis NW, Lim A, Dimalanta ET, Potamousis KD, Apodaca J, Anantharaman TS, Lin J, Yen G, Schwartz DC, Welch RA, Blattner FR. 2001. Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature 409:529-533.
30. Schmidt H. 2001. Shiga-toxin-converting bacteriophages. Res. Microbiol. 152:687-695.
31. Serra-Moreno R, Jofre J, Muniesa M. 2007. Insertion site occupancy by stx2 bacteriophages depends on the locus availability of the host strain chromosome. J. Bacteriol. 189:6645-6654.
32. Shaikh N, Tarr PI. 2003. Escherichia coli O157:H7 Shiga toxin-encoding bacteriophages: integrations, excisions, truncations, and evolutionary implications. J. Bacteriol. 185:3596-3605.
33. Recktenwald J, Schmidt H. 2002. The nucleotide sequence of Shiga toxin (Stx) 2e-encoding phage phiP27 is not related to other Stx phage genomes, but the modular genetic structure is conserved. Infect. Immun. 70:1896-1908.
34. Patridge EV, Ferry JG. 2006. WrbA from Escherichia coli and Archaeoglobus fulgidus is an NAD(P)H:quinone oxidoreductase. J. Bacteriol. 188: 3498-3506.
35. Koch C, Hertwig S, Appel B. 2003. Nucleotide sequence of the integration site of the temperate bacteriophage 6220, which carries the Shiga toxin gene stx(1ox3). J. Bacteriol. 185:6463-6466.
36. Koch C, Hertwig S, Lurz R, Appel B, Beutin L. 2001. Isolation of a lysogenic bacteriophage carrying the stx(1(OX3)) gene, which is closely associated with Shiga toxin-producing Escherichia coli strains from sheep and humans. J. Clin. Microbiol. 39:3992-3998.
37. Creuzburg K, Kohler B, Hempel H, Schreier P, Jacobs E, Schmidt H. 2005. Genetic structure and chromosomal integration site of the cryptic prophage CP-1639 encoding Shiga toxin 1. Microbiology 151:941-950.
38. Ohnishi M, Terajima J, Kurokawa K, Nakayama K, Murata T, Tamura K, Ogura Y, Watanabe H, Hayashi T. 2002. Genomic diversity of enterohemorrhagic Escherichia coli O157 revealed by whole genome PCR scanning. Proc. Natl. Acad. Sci. U. S. A. 99:17043-17048.
39. Jerse AE, Yu J, Tall BD, Kaper JB. 1990. A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc. Natl. Acad. Sci. U. S. A. 87:7839-7843.
40. McDaniel TK, Jarvis KG, Donnenberg MS, Kaper JB. 1995. A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens. Proc. Natl. Acad. Sci. U. S. A. 92:1664-1668.
41. Tauschek M, Strugnell RA, Robins-Browne RM. 2002. Characterization and evidence of mobilization of the LEE pathogenicity island of rabbitspecific strains of enteropathogenic Escherichia coli. Mol. Microbiol. 44: 1533-1550.
42. Müller D, Benz I, Liebchen A, Gallitz I, Karch H, Schmidt MA. 2009. Comparative analysis of the locus of enterocyte effacement and its flanking regions. Infect. Immun. 77:3501-3513.
43. Shen S, Mascarenhas M, Rahn K, Kaper JB, Karmali MA. 2004. Evidence for a hybrid genomic island in verocytotoxin-producing Escherichia coli CL3 (serotype O113:H21) containing segments of EDL933 (serotype O157:H7) O islands 122 and 48. Infect. Immun. 72:1496-1503.
44. Girardeau JP, Bertin Y, Martin C. 2009. Genomic analysis of the PAI ICL3 locus in pathogenic LEE-negative Shiga toxin-producing Escherichia coli and Citrobacter rodentium. Microbiology 155:1016-1027.
45. Schmidt H, Zhang WL, Hemmrich U, Jelacic S, Brunder W, Tarr PI, Dobrindt U, Hacker J, Karch H. 2001. Identification and characterization of a novel genomic island integrated at selC in locus of enterocyte effacement-negative, Shiga toxin-producing Escherichia coli. Infect. Immun. 69:6863-6873.
46. Herold S, Paton JC, Paton AW. 2009. Sab, a novel autotransporter of locus of enterocyte effacement-negative Shiga-toxigenic Escherichia coli O113:H21, contributes to adherence and biofilm formation. Infect. Immun. 77:3234-3243.
47. Scheutz F, Teel LD, Beutin L, Pierard D, Buvens G, Karch H, Mellmann A, Caprioli A, Tozzoli R, Morabito S, Strockbine NA, Melton-Celsa AR, Sanchez M, Persson S, O'Brien AD. 2012. Multicenter evaluation of a sequence-based protocol for subtyping Shiga toxins and standardizing stx nomenclature. J. Clin. Microbiol. 50:2951-2963.
48. Ewers C, Grobbel M, Stamm I, Kopp PA, Diehl I, Semmler T, Fruth A, Beutlich J, Guerra B, Wieler LH, Guenther S. 2010. Emergence of human pandemic O25:H4-ST131 CTX-M-15 extended-spectrum-Β-lactamase-producing Escherichia coli among companion animals. J. Antimicrob. Chemother. 65:651-660.
49. Zhang WL, Bielaszewska M, Liesegang A, Tschäpe H, Schmidt H, Bitzan M, Karch H. 2000. Molecular characteristics and epidemiological significance of Shiga toxin-producing Escherichia coli O26 strains. J. Clin. Microbiol. 38:2134-2140.
50. Mellmann A, Fruth A, Friedrich AW, Wieler LH, Harmsen D, Werber D, Middendorf B, Bielaszewska M, Karch H. 2009. Phylogeny and disease association of Shiga toxin-producing Escherichia coli O91. Emerg. Infect. Dis. 15:1474-1477.
51. Bielaszewska M, Mellmann A, Bletz S, Zhang W, Kock R, Kossow A, Prager R, Fruth A, Orth-Holler D, Marejkova M, Morabito S, Caprioli A, Pierard D, Smith G, Jenkins C, Curova K, Karch H. 1 February 2013. Enterohemorrhagic Escherichia coli O26:H11/H-: a new virulent clone emerges in Europe. Clin. Infect. Dis. doi:10.1093/cid/cit055.
52. Bertin Y, Boukhors K, Livrelli V, Martin C. 2004. Localization of the insertion site and pathotype determination of the locus of enterocyte effacement of Shiga toxin-producing Escherichia coli strains. Appl. Environ. Microbiol. 70:61-68.
53. Moss JE, Cardozo TJ, Zychlinsky A, Groisman EA. 1999. The selCassociated SHI-2 pathogenicity island of Shigella flexneri. Mol. Microbiol. 33:74-83.
54. Vokes SA, Reeves SA, Torres AG, Payne SM. 1999. The aerobactin iron transport system genes in Shigella flexneri are present within a pathogenicity island. Mol. Microbiol. 33:63-73.
55. Welch RA, Burland V, Plunkett G, III, Redford P, Roesch P, Rasko D, Buckles EL, Liou SR, Boutin A, Hackett J, Stroud D, Mayhew GF, Rose DJ, Zhou S, Schwartz DC, Perna NT, Mobley HL, Donnenberg MS, Blattner FR. 2002. Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 99:17020-17024.
56. Swenson DL, Bukanov NO, Berg DE, Welch RA. 1996. Two pathogenicity islands in uropathogenic Escherichia coli J96: cosmid cloning and sample sequencing. Infect. Immun. 64:3736-3743.
57. Lalioui L, Le BC. 2001. afa-8 gene cluster is carried by a pathogenicity island inserted into the tRNAPhe of human and bovine pathogenic Escherichia coli isolates. Infect. Immun. 69:937-948.
58. Jores J, Rumer L, Kiessling S, Kaper JB, Wieler LH. 2001. A novel locus of enterocyte effacement (LEE) pathogenicity island inserted at pheV in bovine Shiga toxin-producing Escherichia coli strain O103:H2. FEMS Microbiol. Lett. 204:75-79.
59. Jores J, Rumer L, Wieler LH. 2004. Impact of the locus of enterocyte effacement pathogenicity island on the evolution of pathogenic Escherichia coli. Int. J. Med. Microbiol. 294:103-113.
60. Ewers C, Bethe A, Semmler T, Guenther S, Wieler LH. 2012. Extendedspectrum beta-lactamase-producing and AmpC-producing Escherichia coli from livestock and companion animals, and their putative impact on public health: a global perspective. Clin. Microbiol. Infect. 18:646-655.
61. Schroeder CM, Meng J, Zhao S, Debroy C, Torcolini J, Zhao C, McDermott PF, Wagner DD, Walker RD, White DG. 2002. Antimicrobial resistance of Escherichia coli O26, O103, O111, O128, and O145 from animals and humans. Emerg. Infect. Dis. 8:1409-1414.
62. Singh R, Schroeder CM, Meng J, White DG, McDermott PF, Wagner DD, Yang H, Simjee S, Debroy C, Walker RD, Zhao S. 2005. Identification of antimicrobial resistance and class 1 integrons in Shiga toxinproducing Escherichia coli recovered from humans and food animals. J. Antimicrob. Chemother. 56:216-219.
63. Ochman H, Selander RK. 1984. Standard reference strains of Escherichia coli from natural populations. J. Bacteriol. 157:690-693.
64. Jaureguy F, Landraud L, Passet V, Diancourt L, Frapy E, Guigon G, Carbonnelle E, Lortholary O, Clermont O, Denamur E, Picard B, Nassif X, Brisse S. 2008. Phylogenetic and genomic diversity of human bacteremic Escherichia coli strains. BMC Genomics 9:560.
65. Creuzburg K, Middendorf B, Mellmann A, Martaler T, Holz C, Fruth A, Karch H, Schmidt H. 2011. Evolutionary analysis and distribution of type III effector genes in pathogenic Escherichia coli from human, animal and food sources. Environ. Microbiol. 13:439-452.
66. Karmali MA, Mascarenhas M, Shen S, Ziebell K, Johnson S, Reid-Smith R, Isaac-Renton J, Clark C, Rahn K, Kaper JB. 2003. Association of genomic O island 122 of Escherichia coli EDL 933 with verocytotoxin-producing Escherichia coli seropathotypes that are linked to epidemic and/or serious disease. J. Clin. Microbiol. 41:4930-4940.
67. Bettelheim KA. 2007. The non-O157 Shiga-toxigenic (verocytotoxigenic) Escherichia coli; under-rated pathogens. Crit. Rev. Microbiol. 33:67-87.
68. Wieler LH, McDaniel TK, Whittam TS, Kaper JB. 1997. Insertion site of the locus of enterocyte effacement in enteropathogenic and enterohemorrhagic Escherichia coli differs in relation to the clonal phylogeny of the strains. FEMS Microbiol. Lett. 156:49-53.
69. Rumer L, Jores J, Kirsch P, Cavignac Y, Zehmke K, Wieler LH. 2003. Dissemination of pheU-and pheV-located genomic islands among enteropathogenic (EPEC) and enterohemorrhagic (EHEC) E. coli and their possible role in the horizontal transfer of the locus of enterocyte effacement (LEE). Int. J. Med. Microbiol. 292:463-475.